mood disorders | CARLAT PUBLISHING

Research Update

Memantine for Trichotillomania and Excoriation Disorder

June 1, 2024

Sarah Azarchi, MD

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Research Update

STAR*D Reanalysis Causes New Debate Over Antidepressant Efficacy

June 1, 2024

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Research Update

Ketamine Fails to Outperform Placebo for Depression in Patients Under Anesthesia

May 1, 2024

Awais Aftab, MD.

Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.

A look whether administering ketamine during general anesthesia changes its ability to treat depression.

Research Update

Mood Switching in Bipolar Disorder

May 1, 2024

Jesse Koskey, MD.

Jesse Koskey, MD. Dr. Koskey has no financial relationships with companies related to this material.

Researchers delve into the occurrence of mood switches in bipolar disorder, and consider both manic and depressive episodes.

Clinical Update

A Personalized Approach to Antidepressant Augmentation

April 1, 2024

Deepti Anbarasan, MD and David Liebers, MD

Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.

David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry.

The authors have no financial relationships with companies related to this material.

The best augmentation strategy varies by patient. Learn which features help personalize the plan.

Research Update

Intermittent Theta-Burst Stimulation for Depression and Suicidality

March 1, 2024

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Although intermittent theta-burst stimulation demonstrates efficacy in depression treatment, we look into how it addresses suicidality?

EXPERT Q&A

Understanding TMS: A Primer for Therapists

February 26, 2024

Faizi Ahmed MD

Faizi Ahmed MD. Affiliate Assistant Professor of Psychiatry and Behavioral Neurosciences at the University of South Florida; private practice at The Neuropsychiatry and TMS Group, Tampa, Florida.

Dr. Ahmed has no financial relationships with companies related to this material.

The relevance of transcranial magnetic stimulation for therapists - what they should know about its mechanism, clinical applications, and emerging research.

Research Update

PEA: A Natural Anti-Inflammatory for Mania?

February 1, 2024

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

After encouraging results in depression, the natural therapy palmitoylethanolamide (PEA) undergoes a randomized controlled trial in bipolar mania.

Expert Q&A

Lithium, Antidepressants, and Bipolar Disorder

February 1, 2024

Michael J. Gitlin, M.D.

Michael J. Gitlin, MD.

Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).

Dr. Gitlin has no financial relationships with companies related to this material.

Practical updates on lithium, antipsychotics, and antidepressants in bipolar disorder.

Research Update

Are Individuals With Major Depressive Symptoms More Likely to Own a Gun in the United States?

January 31, 2024

Susan Siegfreid, MD.

Susan L. Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material.

A survey of gun ownership and gun purchasing plans found that individuals with depressive symptoms were significantly more likely to purchase a gun, or plan to purchase a gun, compared to non-depressed individuals, especially during the COVID-19 pandemic.